CRY is just a CRY baby. Not enough cash to make a good cash tender offer. Stock too low to make a good stock offer. Lousy sales pipeline. Possibly break even if their Bioglue sales get whacked starting mid 2012...that is like only 2 years for now. It would be great if Medafor became a distributor for Tenaxis's Bioglue knock-off. CRY only owns 11% of Medafor, so they can't have a proxy fight to change management (takes 25% in Minnesota I think). CRY baby CRY.
I like your suggested time line. September 2010 works just fine for Medafor shareholders. Why should Medafor expedite them, just because CRY is crying? Time is Medafor's friend and CRY's enemy. Yep, Sept 2010 for the 2009 financial statements would be sweet. Late October, or early November would be the perfect time though. Then we would have 3 quarters of unaudited 2010 financial statements too. Then CRY would be able to wake up to the coffee and see how badly they are getting their butt kicked. As a medafor shareholder, I see no reason to rush this matter. So, CRY baby CRY.